Intravenous Administration of Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery

Intravenous Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00783900

Enrollment

316

Registered

2008-11-03

Start date

2007-01-31

Completion date

2009-12-31

Last updated

2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Biatrial Pacing, Metoprolol

Keywords

Prevention

Brief summary

The aim of the study is to compare the effectiviness of biatrial pacing versus intravenous administration of metoprolol in the prevention of atrial fibrillation after cardiac surgery

Interventions

OTHERmetoprolol, biatrial pacing

Prevention, atrial fibrillation, cardiac surgery, biatrial pacing, metoprolol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* elective CABG and aortic valve cardiac patients, * previous use of beta blocker

Exclusion criteria

* Previous episodes of Atrial fibrillation or flutter, * II or II degree atrioventricular block, uncontrolled heart failure * Sick sinus syndrome

Design outcomes

Primary

Measure	Time frame
biatriac pacing	48 hours
Incidence of atrial fibrillation	48 hours

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026